Ignite Creation Date:
2025-12-25 @ 1:27 AM
Ignite Modification Date:
2025-12-25 @ 11:38 PM
Study NCT ID:
NCT03419494
Status:
UNKNOWN
Last Update Posted:
2018-02-05
First Post:
2018-01-11
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Comparison of Liposomal Doxorubicin and Daunorubicin-containing VDCLD Regimen in the Treatment of Adult ALL Patients
Sponsor:
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-10-10
Start Date Type:
ACTUAL
Primary Completion Date:
2019-01-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2019-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2018-01-11
First Submit QC Date:
None
Study First Post Date:
2018-02-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-01-26
Last Update Post Date:
2018-02-05
Last Update Post Date Type:
ACTUAL